ViCentra Strengthens Leadership Team to Accelerate Growth
ViCentra, a European medical device company, announced two strategic senior leadership appointments following its recent $85 million Series D financing.
Karen Baxter, former VP & GM at Dexcom, joins as SVP Sales, Europe, bringing deep expertise in diabetes device commercialization across Europe.
Jay Little, a long-time commercialization and market access executive at Medtronic Diabetes, takes on the newly created role of Vice President of Strategy & Business Development.
No additional quotes are provided in the text.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: ViCentra appoints new leaders to accelerate!
More News
- Nag: Dam! What happened to the salmon? - Daily Emerald
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- OpenAI completes for-profit shift, gives Microsoft 27% stake
- The United States Is Broke. Americans May Not Care - But the World Does - The Heartland Institute
- From WNBA Court To Playmate Glam: Check Out Kysre Gondrezick’s Sexiest Photos
- Trump administration quietly purges ICE leaders in five cities, including Denver: Sources
- Offshore wind projects feel brunt of Trump policy decisions - Roll Call
- Atalanta v AC Milan: Confirmed line-ups as Rossoneri look to end hosts' unbeaten start
- The Angel Ball Honors Tina Knowles
- Nicole Kidman thriving while Keith Urban struggles after split